Given that targeting FASN during hyperglycaemia-induced, matrix-specific EMT was clearly not a good therapeutic approach, as it increased the invasive potential of the cells, we next determined whether targeting downstream ERα signalling would have a similar effect. Here, ESR1 is linked to Hyperglycemia.